Physicochemical Properties
| Molecular Formula | C75H119N25O17S2 |
| Molecular Weight | 1707.03467202187 |
| Exact Mass | 1705.865 |
| CAS # | 1886973-05-2 |
| Related CAS # | Elabela(19-32) TFA |
| PubChem CID | 127043902 |
| Appearance | White to off-white solid powder |
| LogP | -3.6 |
| Hydrogen Bond Donor Count | 21 |
| Hydrogen Bond Acceptor Count | 23 |
| Rotatable Bond Count | 48 |
| Heavy Atom Count | 119 |
| Complexity | 3580 |
| Defined Atom Stereocenter Count | 14 |
| SMILES | S(C)CC[C@@H](C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(N[C@@H](CO)C(N[C@@H](CCC/N=C(\N)/N)C(N[C@@H](C(C)C)C(N1CCC[C@H]1C(N[C@@H](CC1C=CC=CC=1)C(N1CCC[C@H]1C(=O)O)=O)=O)=O)=O)=O)=O)CC1=CN=CN1)=O)CC(C)C)=O)=O)NC([C@H](CS)NC([C@H](CCC/N=C(\N)/N)NC([C@H](CCC/N=C(\N)/N)NC([C@@H]1CCC(N1)=O)=O)=O)=O)=O |
| InChi Key | LKYSPGTYQNANFL-GYVBEWGNSA-N |
| InChi Code | InChI=1S/C75H119N25O17S2/c1-40(2)33-49(93-67(111)54-20-12-29-98(54)69(113)48(25-32-119-5)91-66(110)53(38-118)96-60(104)45(18-10-27-84-74(78)79)88-59(103)44(17-9-26-83-73(76)77)89-61(105)47-23-24-57(102)87-47)63(107)92-50(35-43-36-82-39-86-43)64(108)95-52(37-101)65(109)90-46(19-11-28-85-75(80)81)62(106)97-58(41(3)4)71(115)99-30-13-21-55(99)68(112)94-51(34-42-15-7-6-8-16-42)70(114)100-31-14-22-56(100)72(116)117/h6-8,15-16,36,39-41,44-56,58,101,118H,9-14,17-35,37-38H2,1-5H3,(H,82,86)(H,87,102)(H,88,103)(H,89,105)(H,90,109)(H,91,110)(H,92,107)(H,93,111)(H,94,112)(H,95,108)(H,96,104)(H,97,106)(H,116,117)(H4,76,77,83)(H4,78,79,84)(H4,80,81,85)/t44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,58-/m0/s1 |
| Chemical Name | (2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2R)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoyl]amino]pentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]pentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | IC50: 8.6 nM (Gαi1) and 166 nM (β-arrestin-2)[1] |
| ln Vitro | The radioligand apelin-13 [Glp65, Nle75 with Ki of 0.93 nM >, tyrosine 77][125I][1] is bound by Elabela (19-32) (analogue 3). When HA-hAPJ receptor is transiently expressed in HEK293 cells, Elabela (19-32) exhibits an EC50 of 36 nM. Apelin-13 and ELA are slightly more effective than Elabela (19-32) at starting receptor internalization [1]. With an EC50 of 1.5 pM, Elabela (19-32) (0.001 to 0.3 nM) alters left ventricular developed pressure (LVDP) in isolated rat hearts that are perfused with Langendorff [1]. |
| ln Vivo | Rat plasma quickly metabolizes Elabela (19-32) (analog 3) (t1/2<2 minutes) [1]. |
| References |
[1]. Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA That Modulates Vascular and Cardiac Functions. J Med Chem. 2016 Apr 14;59(7):2962-72. |
Solubility Data
| Solubility (In Vitro) | H2O: 100 mg/mL (58.58 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (29.29 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 0.5858 mL | 2.9290 mL | 5.8581 mL | |
| 5 mM | 0.1172 mL | 0.5858 mL | 1.1716 mL | |
| 10 mM | 0.0586 mL | 0.2929 mL | 0.5858 mL |